Windtree Therapeutics plans to purchase up to $700 million in BNB cryptocurrencies after the asset reached a new all-time high. The Nasdaq-listed biotech firm is raising $520 million to fund these purchases, having previously announced a $200 million acquisition plan. They will partner with Kraken for asset custody and secure funds through an equity line of credit and a stock-purchase agreement with Build and Build Corp. BNB, currently the fifth-largest digital coin with a market cap of $106.9 billion, was recently trading around $769 after peaking at $808. Windtree's stock has risen by 162% over the past month, despite a 5% drop on the announcement day. The company aims to follow a growing trend among public companies embracing cryptocurrencies to enhance their financial portfolios. Notably, companies like Nano Labs also announced intentions to invest significantly in BNB, showcasing broader institutional interest in digital assets.

Source đź”—